Meningioma
📧 Sign up to get email alerts when something new happens for Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma [Phase 2]
Phase 2 clinical trial update for Zanzalintinib in recurrent or progressive meningioma; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Measurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Therapeutic Trial Using Radioligand Therapy (RLT) [NA]
Preliminary study using PSMA PET imaging to measure PSMA expression in recurrent meningiomas, aiming to support a planned radioligand therap…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
This clinical trial examines tumor genomics, individual risk factors, and external health drivers to understand outcomes in patients with me…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
This clinical trial update indicates the study analyzing cerebrospinal fluid leakage after intracranial tumor surgery is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study [NA]
The HiPPI study is evaluating hypofractionated proton therapy for benign intracranial brain tumors and is currently recruiting. It targets m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
GT Medical Technologies reports that the STaRT GammaTiles brain tumor trial is currently recruiting patients with various brain tumors, incl…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: 3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features [NA]
This clinical trial studies using 3D magnetic resonance elastography (MRE) to evaluate the mechanical properties of meningiomas and relate t…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial [Phase 2]
A Phase 2 trial (PODS) is evaluating post-operative dosing of dexamethasone in brain tumor patients after craniotomy; the study is currently…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND
An ongoing clinical trial (MIND, NCT07282470) investigates epigenetic profiling and liquid biopsy to guide personalized treatment for patien…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study [NA]
A proof-of-concept clinical trial to detect circulating tumour cells in the blood and/or cerebrospinal fluid of patients with recurrent aggr…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) [NA]
A clinical trial evaluating dexmedetomidine for postoperative analgesia and delirium prevention after neurosurgery, currently not recruiting…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Evaluation of the CONVIVO System [NA]
The CONVIVO System is currently recruiting for a clinical trial evaluating its use in brain tumor surgery. It targets glioblastoma, glioma, …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors [Phase 1]
A Phase 1 imaging trial evaluating a zirconium-89 labeled antibody (Zr-89 Crefmirlimab Berdoxam) for Immuno-PET imaging of resectable brain …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas
This trial update describes psychometric validation of the MQOL-FR instrument. It also provides a descriptive assessment of health-related q…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma [Phase 2]
An open-label Phase II trial updates results for nivolumab alone or in combination with ipilimumab in adults with progressive or recurrent m…
-
CLINICAL_TRIALS withdrawal · 2026-01-26Clinical Trial Update: A Study of ONC201 for Refractory Meningioma [Phase 2]
A Phase 2 study of ONC201 for refractory meningioma has been withdrawn.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma [Phase 1]
A Phase 1 trial investigating PET imaging with 68Ga-Dotatate and MRI-guided radiation dose escalation for high-risk or recurrent meningioma …
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Robot-Assisted Neurovascular Intervention [NA]
A robot-assisted neurovascular intervention trial sponsored by Navigantis Inc. is currently recruiting and aims to evaluate treatment approa…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery [Phase 3]
Phase 3 trial is evaluating whether observation or radiation therapy after complete surgical removal is better for newly diagnosed Grade II …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) [Phase 2]
This update covers an ongoing Phase 2 clinical trial (INTUITT-NF2) evaluating targeted therapies for NF2-related schwannomatosis. The study …
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: MEningioma Detection Using Non Contrast MRI TecHniquEs
This clinical trial investigated non-contrast MRI techniques to detect meningioma. The study was terminated, and no results are reported in …
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium
This clinical trial update reports on the concordance and accuracy of MRI in detecting meningiomas using optimized imaging sequences with lo…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent [Phase 2]
Phase 2 ascending-dose study of RVP-001, a manganese-based MRI contrast agent, completed to assess safety and preliminary efficacy in CNS le…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) [NA]
The HOBSCOTCH-CA trial, a home-based self-management and cognitive training program for brain cancer patients, is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. [Phase 4]
A Phase 4 clinical trial evaluating the use of the radiotracer 68-Gallium DOTATATE PET/MRI for diagnosing and managing somatostatin receptor…